Target intelligence / Profile preview

G protein-gated inwardly rectifying potassium channel (IKACh) (IKACh)

Target
IKACh
Molecular classification
Ion channel, Inward rectifier potassium channel, G protein-gated channel
01

Overview

The G protein-gated inwardly rectifying potassium channel (IKACh) is a cardiac potassium channel that mediates the acetylcholine-sensitive K+ current in atrial and nodal myocytes. It is a heterotetrameric structure typically composed of Kir3.1 (GIRK1) and Kir3.4 (GIRK4) subunits, and is activated by direct binding of Gβγ subunits from muscarinic M2 receptor–coupled G-proteins in response to parasympathetic stimulation. IKACh activation increases potassium permeability, causing membrane hyperpolarization and shortening of the cardiac action potential, especially in the atria, thereby slowing the heart rate and facilitating vagal control of cardiac rhythm. IKACh is implicated in multiple cardiac pathologies, especially arrhythmias such as atrial fibrillation, and is a validated drug target for modulating cardiac electrical behavior.

Other names
Acetylcholine-activated potassium channelMuscarinic-gated atrial potassium channelGIRK1/GIRK4 channel (Kir3.1/Kir3.4 channel)G protein-coupled inward rectifier potassium channelAcetylcholine-sensitive K+ current channel
02

Mechanism of action

Blockage of IKACh: increases heart rate, used in bradycardia or to terminate vagal-induced arrhythmias; Activation of IKACh: slows heart rate via hyperpolarization and shortening of action potential duration

03

Biological functions

Cardiac electrical signalingHeart rate regulationMediation of parasympathetic effects on the heartTermination of action potentials in atrial and nodal tissue
04

Disease associations

Cardiovascular diseaseArrhythmias (notably atrial fibrillation)Bradycardia
05

Safety considerations

Inhibition can cause tachycardia or promote arrhythmiaExcessive activation can induce bradycardia, atrioventricular block, or asystoleTissue-specificity is a therapeutic challenge due to presence in both atria and other tissues
06

Interacting drugs

Atropine (acts indirectly by blocking upstream muscarinic receptors)

3 more in the full profile.

07

Biomarkers

Atrial IKACh current magnitude (as an indicator of vagal tone or atrial electrical remodeling)

Beyond the preview

Go deeper on G protein-gated inwardly rectifying potassium channel (IKACh) (IKACh).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-gated inwardly rectifying potassium channel (IKACh) (IKACh).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call